SHSE:688443 (China)
Â
Ordinary Shares - Class A
Â¥
31.80
(-2.33%)
Jul 16
Business Description
Chongqing Genrix Biopharmaceutical Co Ltd
Share Class Description:
SHSE:688443: Ordinary Shares - Class ACompare
Compare
Traded in other countries / regions
688443.China IPO Date
2023-06-20Description
Chongqing Genrix Biopharmaceutical Co Ltd is engaged in the research & development, production and sales of antibody drugs. The company has a total of more than ten products under research covering three major therapeutic areas. The progress of core products is leading, and some product pipelines are as follows; autoimmune disease, infectious disease, and tumor. Its product Xeligekimab injection (Xeligekimab) is a recombinant fully human anti-IL-17A monoclonal antibody independently developed by the company, which has been accepted by the National Medical Products Administration (NMPA) for new drug marketing applications.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.29 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | -0.88 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 8.85 | |||||
Beneish M-Score | -2.97 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.15 | |||||
9-Day RSI | 56.53 | |||||
14-Day RSI | 51.42 | |||||
6-1 Month Momentum % | -11.48 | |||||
12-1 Month Momentum % | -1.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 24.16 | |||||
Quick Ratio | 23.66 | |||||
Cash Ratio | 22.97 | |||||
Days Inventory | 31635.37 | |||||
Days Sales Outstanding | 15.36 | |||||
Days Payable | 42643.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.61 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 42.26 | |||||
Operating Margin % | -68406.71 | |||||
Net Margin % | -68408.24 | |||||
FCF Margin % | -43296.15 | |||||
ROE % | -33.52 | |||||
ROA % | -24.19 | |||||
ROIC % | -128.93 | |||||
ROC (Joel Greenblatt) % | -144.61 | |||||
ROCE % | -24.09 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 10600.01 | |||||
PB Ratio | 4.39 | |||||
Price-to-Tangible-Book | 4.45 | |||||
EV-to-EBIT | -13.44 | |||||
EV-to-EBITDA | -13.48 | |||||
EV-to-Revenue | 8794.33 | |||||
EV-to-FCF | -21.06 | |||||
Price-to-Net-Current-Asset-Value | 5.53 | |||||
Price-to-Net-Cash | 5.93 | |||||
Earnings Yield (Greenblatt) % | -7.44 | |||||
FCF Yield % | -4.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chongqing Genrix Biopharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1.117 | ||
EPS (TTM) (Â¥) | -2.22 | ||
Beta | 0 | ||
Volatility % | 50.13 | ||
14-Day RSI | 51.42 | ||
14-Day ATR (Â¥) | 1.858382 | ||
20-Day SMA (Â¥) | 30.847 | ||
12-1 Month Momentum % | -1.04 | ||
52-Week Range (Â¥) | 24.49 - 45.51 | ||
Shares Outstanding (Mil) | 366.68 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Chongqing Genrix Biopharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Chongqing Genrix Biopharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Chongqing Genrix Biopharmaceutical Co Ltd Frequently Asked Questions
What is Chongqing Genrix Biopharmaceutical Co Ltd(SHSE:688443)'s stock price today?
The current price of SHSE:688443 is ¥31.80. The 52 week high of SHSE:688443 is ¥45.51 and 52 week low is ¥24.49.
When is next earnings date of Chongqing Genrix Biopharmaceutical Co Ltd(SHSE:688443)?
The next earnings date of Chongqing Genrix Biopharmaceutical Co Ltd(SHSE:688443) is .
Does Chongqing Genrix Biopharmaceutical Co Ltd(SHSE:688443) pay dividends? If so, how much?
Chongqing Genrix Biopharmaceutical Co Ltd(SHSE:688443) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |